EYE
National Vision Holdings, Inc. · Consumer Discretionary · Specialty Retail
Last
$26.95
−$0.31 (−1.12%) 4:00 PM ET
After hours $27.00 +$0.05 (+0.17%) 11:09 PM ET
Prev close $27.26
Open $26.74
Day high $27.37
Day low $26.21
Volume 1,362,033
Avg vol 1,161,862
Mkt cap
$2.14B
P/E ratio
-898.47
FY Revenue
$1.92B
EPS
-0.03
Gross Margin
58.69%
Sector
Consumer Discretionary
AI report sections
EYE
National Vision Holdings, Inc.
No AI report section text found yet for this symbol.
Volume vs average
Intraday (cumulative)
+66% (Above avg)
Vol/Avg: 1.66×
RSI
50.22 (Neutral)
Neutral (40–60)
MACD momentum
Intraday
+0.01 (Strong)
MACD: 0.04 Signal: 0.03
Short-Term
-0.13 (Weak)
MACD: -0.20 Signal: -0.07
Long-Term
-0.10 (Weak)
MACD: -0.23 Signal: -0.13
Intraday trend score 66.00

Latest news

EYE 12 articles Positive: 3 Neutral: 0 Negative: 0
Positive The Motley Fool • Jake Lerch
New Investment Thesis: Fund Picks Optical Retailer Stock

Bain Capital Public Equity acquired 199,934 shares of National Vision Holdings, representing a $5.84 million investment in the optical retail sector. The stock has performed well in 2025, with a 136% year-to-date return, and the company is focusing on cost-cutting and expansion strategies.

EYE optical retail investment stock performance Bain Capital National Vision Holdings
Sentiment note

Strong stock performance in 2025 (136% year-to-date), solid quarterly results, cost-cutting initiatives, and expansion plans indicate positive business trajectory

Positive Investing.com • Marketbeat.Com
Keep Your Eye on This Stock, It Just Got a Rare Double Upgrade

National Vision Holdings Inc (EYE) has seen a surge in its stock price after a strong earnings report and a rare double upgrade from Bank of America. The company's strategic initiatives and focus on higher-value customer segments have driven the turnaround, making it a stock to watch for potential long-term gains.

EYE WMT National Vision Holdings Bank of America earnings upgrade
Sentiment note

The company reported strong Q1 earnings, raised its full-year guidance, and received a rare double upgrade from Bank of America, indicating that its strategic initiatives are bearing fruit and the outlook for the company is positive.

Positive Zacks Investment Research • N/A
Will WATCHMAN Sales Aid Boston Scientific's (BSX) Q2 Earnings? - Zacks Investment Research

Boston Scientific Corporation is scheduled to report its Q2 2024 results on July 24. The company is expected to report revenue growth of around 11.7% and adjusted earnings of 58 cents per share. However, the company may face challenges from a challenging supply environment, rising costs, and healthcare staffing shortages.

BSX EYE GKOS TNDM Boston Scientific Corporation Q2 2024 earnings revenue growth adjusted earnings
Sentiment note

The article mentions National Vision as a stock that has a good chance of beating earnings estimates, based on its positive Earnings ESP and Zacks Rank.

Unknown Zacks Investment Research • Zacks Equity Research
National Vision (EYE) Gains Market Share Despite Macro Woes

National Vision (EYE) continues to execute core growth initiatives and further invest in strengthening competitive advantages.

JYNT MEDP EYE HIMS
Unknown Zacks Investment Research • Zacks Equity Research
National Vision (EYE) Down 4% Since Last Earnings Report: Can It Rebound?

National Vision (EYE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

EYE LNTH
Unknown Zacks Investment Research • Zacks Equity Research
National Vision (EYE) Q1 Earnings Beat Estimates, Margins Down

National Vision (EYE) delivers improved revenues in the first quarter of 2024 in a challenging macro environment.

EHC EYE INSP HIMS
Unknown Zacks Investment Research • Zacks Equity Research
National Vision (EYE) Q1 Earnings Top Estimates

National Vision (EYE) delivered earnings and revenue surprises of 7.14% and 2.68%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

EYE MDT
Unknown Zacks Investment Research • Zacks Equity Research
Jushi Holdings Inc. (JUSHF) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Jushi Holdings Inc. (JUSHF) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

JUSHF EYE
Unknown Zacks Investment Research • Zacks Equity Research
National Vision (EYE) Down 4.1% Since Last Earnings Report: Can It Rebound?

National Vision (EYE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

EYE MDT
Unknown Zacks Investment Research • Zacks Equity Research
Here's Why You Should Retain National Vision (EYE) Stock Now

The strong execution of strategic initiatives and robust financial stability bode well for National Vision (EYE).

SYK DVA CAH EYE
Unknown Zacks Investment Research • Zacks Equity Research
National Vision (EYE) Q4 Earnings Top Estimates, Margins Fall

National Vision's (EYE) Q4 adjusted comparable store sales growth is driven by ongoing strength within America's Best and Eyeglass World sales.

SYK CAH COR EYE
Unknown Zacks Investment Research • Zacks Equity Research
Stock Market News for Feb 28, 2024

Wall Street closed with a mixed performance on Tuesday as investors awaited crucial inflation data, which could influence the Federal Reserve's interest rate decisions.

LOW AZO EYE
News and sentiment labels describe article tone and are provided for research purposes only. They are not trading recommendations or forecasts.
Trade Ranks, LLC is not a registered investment adviser or broker-dealer. All rankings and AI reports are for informational and educational purposes only and are not personalized advice. Investing involves risk. Policy Portal